Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Macular Degeneration (AMD) and Other Retinal Diseases
1.2 Key Market Segments
1.2.1 Macular Degeneration (AMD) and Other Retinal Diseases Segment by Type
1.2.2 Macular Degeneration (AMD) and Other Retinal Diseases Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Macular Degeneration (AMD) and Other Retinal Diseases Market Overview
2.1 Global Market Overview
2.1.1 Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Macular Degeneration (AMD) and Other Retinal Diseases Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Macular Degeneration (AMD) and Other Retinal Diseases Market Competitive Landscape
3.1 Global Macular Degeneration (AMD) and Other Retinal Diseases Sales by Manufacturers (2019-2024)
3.2 Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue Market Share by Manufacturers (2019-2024)
3.3 Macular Degeneration (AMD) and Other Retinal Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Macular Degeneration (AMD) and Other Retinal Diseases Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Macular Degeneration (AMD) and Other Retinal Diseases Sales Sites, Area Served, Product Type
3.6 Macular Degeneration (AMD) and Other Retinal Diseases Market Competitive Situation and Trends
3.6.1 Macular Degeneration (AMD) and Other Retinal Diseases Market Concentration Rate
3.6.2 Global 5 and 10 Largest Macular Degeneration (AMD) and Other Retinal Diseases Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Macular Degeneration (AMD) and Other Retinal Diseases Industry Chain Analysis
4.1 Macular Degeneration (AMD) and Other Retinal Diseases Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Macular Degeneration (AMD) and Other Retinal Diseases Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Macular Degeneration (AMD) and Other Retinal Diseases Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Macular Degeneration (AMD) and Other Retinal Diseases Sales Market Share by Type (2019-2024)
6.3 Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size Market Share by Type (2019-2024)
6.4 Global Macular Degeneration (AMD) and Other Retinal Diseases Price by Type (2019-2024)
7 Macular Degeneration (AMD) and Other Retinal Diseases Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Macular Degeneration (AMD) and Other Retinal Diseases Market Sales by Application (2019-2024)
7.3 Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size (M USD) by Application (2019-2024)
7.4 Global Macular Degeneration (AMD) and Other Retinal Diseases Sales Growth Rate by Application (2019-2024)
8 Macular Degeneration (AMD) and Other Retinal Diseases Market Segmentation by Region
8.1 Global Macular Degeneration (AMD) and Other Retinal Diseases Sales by Region
8.1.1 Global Macular Degeneration (AMD) and Other Retinal Diseases Sales by Region
8.1.2 Global Macular Degeneration (AMD) and Other Retinal Diseases Sales Market Share by Region
8.2 North America
8.2.1 North America Macular Degeneration (AMD) and Other Retinal Diseases Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Macular Degeneration (AMD) and Other Retinal Diseases Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Macular Degeneration (AMD) and Other Retinal Diseases Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Macular Degeneration (AMD) and Other Retinal Diseases Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Macular Degeneration (AMD) and Other Retinal Diseases Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Regeneron Pharmaceuticals
9.1.1 Regeneron Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
9.1.2 Regeneron Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
9.1.3 Regeneron Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Product Market Performance
9.1.4 Regeneron Pharmaceuticals Business Overview
9.1.5 Regeneron Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases SWOT Analysis
9.1.6 Regeneron Pharmaceuticals Recent Developments
9.2 Bayer HealthCare
9.2.1 Bayer HealthCare Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
9.2.2 Bayer HealthCare Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
9.2.3 Bayer HealthCare Macular Degeneration (AMD) and Other Retinal Diseases Product Market Performance
9.2.4 Bayer HealthCare Business Overview
9.2.5 Bayer HealthCare Macular Degeneration (AMD) and Other Retinal Diseases SWOT Analysis
9.2.6 Bayer HealthCare Recent Developments
9.3 Novartis
9.3.1 Novartis Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
9.3.2 Novartis Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
9.3.3 Novartis Macular Degeneration (AMD) and Other Retinal Diseases Product Market Performance
9.3.4 Novartis Macular Degeneration (AMD) and Other Retinal Diseases SWOT Analysis
9.3.5 Novartis Business Overview
9.3.6 Novartis Recent Developments
9.4 Roche
9.4.1 Roche Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
9.4.2 Roche Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
9.4.3 Roche Macular Degeneration (AMD) and Other Retinal Diseases Product Market Performance
9.4.4 Roche Business Overview
9.4.5 Roche Recent Developments
9.5 Kanghong Pharma
9.5.1 Kanghong Pharma Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
9.5.2 Kanghong Pharma Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
9.5.3 Kanghong Pharma Macular Degeneration (AMD) and Other Retinal Diseases Product Market Performance
9.5.4 Kanghong Pharma Business Overview
9.5.5 Kanghong Pharma Recent Developments
9.6 Merck
9.6.1 Merck Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
9.6.2 Merck Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
9.6.3 Merck Macular Degeneration (AMD) and Other Retinal Diseases Product Market Performance
9.6.4 Merck Business Overview
9.6.5 Merck Recent Developments
9.7 Allergan
9.7.1 Allergan Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
9.7.2 Allergan Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
9.7.3 Allergan Macular Degeneration (AMD) and Other Retinal Diseases Product Market Performance
9.7.4 Allergan Business Overview
9.7.5 Allergan Recent Developments
9.8 Santen Pharmaceutical
9.8.1 Santen Pharmaceutical Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
9.8.2 Santen Pharmaceutical Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
9.8.3 Santen Pharmaceutical Macular Degeneration (AMD) and Other Retinal Diseases Product Market Performance
9.8.4 Santen Pharmaceutical Business Overview
9.8.5 Santen Pharmaceutical Recent Developments
9.9 GlaxoSmithKline Pharmaceuticals
9.9.1 GlaxoSmithKline Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
9.9.2 GlaxoSmithKline Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
9.9.3 GlaxoSmithKline Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Product Market Performance
9.9.4 GlaxoSmithKline Pharmaceuticals Business Overview
9.9.5 GlaxoSmithKline Pharmaceuticals Recent Developments
9.10 Pfizer
9.10.1 Pfizer Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
9.10.2 Pfizer Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
9.10.3 Pfizer Macular Degeneration (AMD) and Other Retinal Diseases Product Market Performance
9.10.4 Pfizer Business Overview
9.10.5 Pfizer Recent Developments
9.11 Acucela
9.11.1 Acucela Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
9.11.2 Acucela Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
9.11.3 Acucela Macular Degeneration (AMD) and Other Retinal Diseases Product Market Performance
9.11.4 Acucela Business Overview
9.11.5 Acucela Recent Developments
9.12 Valent Pharmaceuticals
9.12.1 Valent Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
9.12.2 Valent Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
9.12.3 Valent Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Product Market Performance
9.12.4 Valent Pharmaceuticals Business Overview
9.12.5 Valent Pharmaceuticals Recent Developments
9.13 IVERIC
9.13.1 IVERIC Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
9.13.2 IVERIC Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
9.13.3 IVERIC Macular Degeneration (AMD) and Other Retinal Diseases Product Market Performance
9.13.4 IVERIC Business Overview
9.13.5 IVERIC Recent Developments
10 Macular Degeneration (AMD) and Other Retinal Diseases Market Forecast by Region
10.1 Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size Forecast
10.2 Global Macular Degeneration (AMD) and Other Retinal Diseases Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Macular Degeneration (AMD) and Other Retinal Diseases Market Size Forecast by Country
10.2.3 Asia Pacific Macular Degeneration (AMD) and Other Retinal Diseases Market Size Forecast by Region
10.2.4 South America Macular Degeneration (AMD) and Other Retinal Diseases Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Macular Degeneration (AMD) and Other Retinal Diseases by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Macular Degeneration (AMD) and Other Retinal Diseases Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Macular Degeneration (AMD) and Other Retinal Diseases by Type (2025-2030)
11.1.2 Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Macular Degeneration (AMD) and Other Retinal Diseases by Type (2025-2030)
11.2 Global Macular Degeneration (AMD) and Other Retinal Diseases Market Forecast by Application (2025-2030)
11.2.1 Global Macular Degeneration (AMD) and Other Retinal Diseases Sales (K Units) Forecast by Application
11.2.2 Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
